Eli Lilly’s experimental obesity pill helped patients lose 9.6% of their body weight in a trial that moves the company one step closer to a potential approval https://t.co/Iaujssmvki ...

Viking Therapeutics plunged in early trading on Tuesday after its experimental obesity pill disappointed in a mid-stage study, marking another weaker-than-expected result for an oral alternative to popular weight-loss injections https://t.co/7dQrwfjyjo ...